DrugPatentWatch Database Preview
Teligent Company Profile
What is the competitive landscape for TELIGENT, and what generic and branded alternatives to TELIGENT drugs are available?
TELIGENT has forty-six approved drugs.
Summary for Teligent
| US Patents: | 0 |
| Tradenames: | 37 |
| Ingredients: | 32 |
| NDAs: | 46 |
| Patent Litigation for Teligent: | See patent lawsuits for Teligent |
Drugs and US Patents for Teligent
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teligent | NORFLEX | orphenadrine citrate | INJECTABLE;INJECTION | 013055-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Teligent Pharma Inc | DOBUTAMINE HYDROCHLORIDE | dobutamine hydrochloride | INJECTABLE;INJECTION | 074098-001 | Feb 21, 1995 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Teligent Pharma Inc | DESOXIMETASONE | desoximetasone | OINTMENT;TOPICAL | 208101-001 | Feb 25, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Teligent Pharma Inc | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | LOTION;TOPICAL | 204608-001 | Jul 7, 2016 | AT | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Teligent | CEFOTAN | cefotetan disodium | INJECTABLE;INJECTION | 050588-002 | Dec 27, 1985 | AP | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ||||
| Teligent Pharma Inc | HALOBETASOL PROPIONATE | halobetasol propionate | OINTMENT;TOPICAL | 209978-001 | Mar 20, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Teligent
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Teligent | ZANTAC | ranitidine hydrochloride | INJECTABLE;INJECTION | 019090-001 | Oct 19, 1984 | 4,128,658 | ➤ Sign Up |
| Teligent | ZANTAC IN PLASTIC CONTAINER | ranitidine hydrochloride | INJECTABLE;INJECTION | 019593-002 | Sep 27, 1991 | 4,128,659 | ➤ Sign Up |
| Teligent | ZANTAC IN PLASTIC CONTAINER | ranitidine hydrochloride | INJECTABLE;INJECTION | 019593-002 | Sep 27, 1991 | 4,128,658 | ➤ Sign Up |
| Teligent | ZANTAC | ranitidine hydrochloride | INJECTABLE;INJECTION | 019090-001 | Oct 19, 1984 | 4,585,790*PED | ➤ Sign Up |
| Teligent | ZANTAC IN PLASTIC CONTAINER | ranitidine hydrochloride | INJECTABLE;INJECTION | 019593-001 | Dec 17, 1986 | 4,585,790*PED | ➤ Sign Up |
| Teligent | ZANTAC IN PLASTIC CONTAINER | ranitidine hydrochloride | INJECTABLE;INJECTION | 019593-001 | Dec 17, 1986 | 4,128,658 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
